Quick Answer
LEXICON PHARMACEUTICALS, INC. reported Long Term Debt of $49.41 million for the year ending 2025.
- LEXICON PHARMACEUTICALS, INC. showed a decrease of -50.7% in Long Term Debt from 2024 to 2025.
- This data is from LEXICON PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $24.19 million | Q3 2011: $23.83 million | Q1 2012: $23.06 million | Q2 2012: $22.68 million | Q3 2012: $22.28 million | Q1 2013: $21.46 million | Q2 2013: $0.00 | Q3 2013: $20.61 million | Q1 2014: $19.71 million | Q2 2014: $19.26 million | Q3 2014: $0.00 | Q1 2015: $87.50 million | Q2 2015: $87.50 million | Q3 2015: $87.50 million | Q1 2016: $100.55 million | Q2 2016: $84.91 million | Q3 2016: $85.04 million | Q1 2017: $85.27 million | Q2 2017: $85.38 million | Q3 2017: $85.51 million | Q1 2018: $231.88 million | Q2 2018: $232.20 million | Q3 2018: $243.83 million | Q1 2019: $243.91 million | Q2 2019: $243.95 million | Q3 2019: $233.84 million | Q1 2020: $234.49 million | Q2 2020: $234.81 million | Q3 2020: $11.63 million | Q1 2022: $23.48 million | Q2 2022: $23.63 million | Q3 2022: $23.78 million | Q1 2023: $48.85 million | Q2 2023: $98.77 million | Q3 2023: $99.27 million | Q1 2024: $99.87 million | Q2 2024: $99.50 million | Q3 2024: $99.90 million | Q1 2025: $58.64 million | Q2 2025: $56.11 million | Q3 2025: $56.51 million.
- Over the full 16 years of available data (2010 to 2025), LEXICON PHARMACEUTICALS, INC.'s Long Term Debt has grown by 80.7%.
- Historical annual values: Fiscal year 2025: $49.41 million | Fiscal year 2024: $100.30 million | Fiscal year 2023: $99.51 million | Fiscal year 2022: $48.58 million | Fiscal year 2021: $0.00 | Fiscal year 2020: $0.00 | Fiscal year 2019: $234.17 million | Fiscal year 2018: $243.89 million | Fiscal year 2017: $231.58 million | Fiscal year 2016: $85.17 million | Fiscal year 2015: $100.96 million | Fiscal year 2014: $87.50 million | Fiscal year 2013: $20.17 million | Fiscal year 2012: $21.88 million | Fiscal year 2011: $23.45 million | Fiscal year 2010: $27.35 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: